iNCOVACC NASAL VACCINE
INDIA'S 1st INTRANASAL COVID VACCINE MADE BY BHARAT BIOTECH
Published By Livemint | 27 Dec, 2022
Bharat Biotech's intranasal Covid vaccine iNCOVACC has been approved by govt
iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine
It will be administered as a booster dose for those aged 18 years and above
It will be priced at
₹
800 for private hospitals &
₹
325 for government hospitals
iNCOVACC will be rolled out in the fourth week of January
It is likely to be introduced on the Co-WIN platform on 30 Dec
CLICK FOR MORE VISUAL STORIES